36C24724Q0359.docx

Special Notice Special Notice

GENERAL INFORMATION

Central Alabama Veterans Health Care

215 Perry Hill Road Montgomery AL 36109-3798

POINT OF CONTACT*

Contracting Officer Earnest Ellison Earnest.Ellison@va.gov

ADDITIONAL INFORMATION

DESCRIPTION

* **INTENT TO SOLE SOURCE NOTICE-***

NOTICE OF INTENT TO SOLE SOURCE This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals.

The Department of Veterans Affairs, Atlanta, Georgia on behalf of the Atlanta VA Health Care System, 1670 Clairmont Road, Decatur, Ga. intends to award a sole source procurement for the Adstiladrin Drugs.

Item Description: CLIN 0001: QTY 4 each: (2 doses per patient).

This requirement is a onetime brand name requirement. Ferring Pharmaceuticals, Inc is the manufacture for the Adstiladrin Drugs. Ferring Pharmaceuticals, Inc unique entity ID number D6ATBE6Y96L5. The applicable NAICS code for this procurement is 325412- Pharmaceutical Preparation Manufacturing, with a business size standard of 1,250 employees.

Furthermore, the Contracting Officer has determined that there are no opportunities exist for competition for either Service-Disabled Veteran Owned Small Businesses (SDVOSB), Veteran Owned Small Businesses (VOSB) and Small Businesses. The Contracting Officer has determined that ASD Specialty Healthcare, LLC, is an authorized reseller for Ferring Pharmaceuticals, Inc and there are no other providers that are authorized to resell or maintain the Adstiladrin Drugs.

Therefore, the Government intends to solicit and negotiate with only one source under the Authority of FAR 13.106-1 which states that Contracting Officers may solicit from one source if the Contracting Officer determines that the circumstances of the contract action deem only one source reasonably available ASD Specialty Healthcare, LLC, is the only exclusive reseller for this opportunity for the Atlanta VA Health Care System Pharmacy.

This notice of intent is neither a formal solicitation nor a request for competitive proposals. No solicitation document is available and telephone requests will not be honored. No award will be made on the basis of unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear, compelling and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this action based on this notice is solely within the discretion of the Government.

All inquiries and concerns must be addressed in writing via e-mail to Earnest Ellison, earnest.ellison@va.gov with the following information referenced in the subject line, Adstiladrin Drugs. All interested parties who are responsible, certified, and capable may identify their interest and may submit a capabilities statement no later than 3:00 PM Eastern Standard Time (EST) on 17 February 2024 to Earnest Ellison, earnest.ellison@va.gov. The interested parties bear full responsibility to ensure complete transmission and timely receipt.

Special Notice